Buy MITOMYCIN FOR INJECTION 20 MG MITOMYCIN

Mitomycin for Injection 20 mg is a powder for solution used in intravenous treatments. This medication is often associated with certain cancer therapies and is supplied by Teva Canada Limited.

Strength

20 MG

Pack Size

10ML

Manufacturer / TM Owner

TEVA CANADA LIMITED

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

Mitomycin for Injection 20 mg is typically used in the management of specific types of cancer. It is administered intravenously and is often part of a broader treatment plan. The primary use of Mitomycin is to target and inhibit the growth of cancer cells, though it is essential to consult healthcare professionals for personalized advice on what Mitomycin is used for.

Side Effects

Common effects of Mitomycin for Injection 20 mg may include nausea, vomiting, and fatigue. Some individuals might experience more severe reactions, such as bone marrow suppression. It is important to monitor for any adverse effects and report them to a healthcare provider promptly.

Precautions & Warnings

Mitomycin for Injection 20 mg should be handled with care, as it is a potent medication. It is crucial to follow proper administration protocols to avoid contamination and ensure safety. Patients should be aware of potential allergic reactions and inform their healthcare provider of any pre-existing conditions before starting treatment.

Avoid Interactions

Mitomycin for Injection 20 mg may interact with other medications, particularly those that affect the bone marrow or immune system. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol and certain foods may also influence the effectiveness and safety of Mitomycin.

References

Frequently Asked Questions

Mitomycin for Injection 20 mg is commonly used in the treatment of certain types of cancer, often as part of a broader treatment plan.

Mitomycin for Injection 20 mg is administered intravenously after being reconstituted from its powder form.

Common side effects may include nausea, vomiting, fatigue, and bone marrow suppression. Severe reactions should be reported to a healthcare provider.

Mitomycin may interact with other medications, so it is important to consult a healthcare provider before combining it with other treatments.

Precautions include proper handling to avoid contamination, monitoring for allergic reactions, and informing healthcare providers of any pre-existing conditions.

Published by GNH India Pharmaceuticals Limited

Last updated: 18 May 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.